PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea flag South Korea · Delayed Price · Currency is KRW
580,000
+2,000 (0.35%)
Sep 29, 2025, 3:30 PM KST

PharmaResearch Revenue

PharmaResearch had revenue of 140.61B KRW in the quarter ending June 30, 2025, with 69.19% growth. This brings the company's revenue in the last twelve months to 449.81B, up 51.66% year-over-year. In the year 2024, PharmaResearch had annual revenue of 350.12B with 34.14% growth.

Revenue (ttm)
449.81B
Revenue Growth
+51.66%
P/S Ratio
13.35
Revenue / Employee
999.58M
Employees
450
Market Cap
6,005.22B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024350.12B89.10B34.14%
Dec 31, 2023261.01B66.25B34.02%
Dec 31, 2022194.76B40.68B26.40%
Dec 31, 2021154.08B45.34B41.69%
Dec 31, 2020108.75B24.87B29.66%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics5,031.69B
Celltrion3,748.95B
ALTEOGEN158.06B
Yuhan2,165.44B
SK Biopharmaceuticals620.28B
Peptron5.18B
LigaChem Biosciences148.28B
HLB Co., Ltd.75.57B
Revenue Rankings